Separation Systems for Commercial Biotechnology Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4115157
- 121 Pages
- November 2020
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Separation Systems for Commercial Biotechnology market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Separation Systems for Commercial Biotechnology market segmented into
Microarray
Lab-on-a-chip
Biochip
Magnetic separation
Chromatography
Flow cytometry
Membrane filtration
Electrophoresis
Centrifugation
Based on the end-use, the global Separation Systems for Commercial Biotechnology market classified into
Pharmaceutical
Food & Cosmetics
Agriculture
Others
Based on geography, the global Separation Systems for Commercial Biotechnology market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Thermo Fisher Scientific
GE Healthcare
Agilent Technologies;Shimadzu Corporation
bioM rieux SA
Bio-Rad Laboratories, Inc.
Hitachi Koki Co., Ltd.
Merck & Co., Inc.
QIAGEN
WATERS
Sartorius
PerkinElmer, Inc.
Danaher
Miltenyi Biotec
BD
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL SEPARATION SYSTEMS FOR COMMERCIAL BIOTECHNOLOGY INDUSTRY
2.1 Summary about Separation Systems for Commercial Biotechnology Industry
2.2 Separation Systems for Commercial Biotechnology Market Trends
2.2.1 Separation Systems for Commercial Biotechnology Production & Consumption Trends
2.2.2 Separation Systems for Commercial Biotechnology Demand Structure Trends
2.3 Separation Systems for Commercial Biotechnology Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Microarray
4.2.2 Lab-on-a-chip
4.2.3 Biochip
4.2.4 Magnetic separation
4.2.5 Chromatography
4.2.6 Flow cytometry
4.2.7 Membrane filtration
4.2.8 Electrophoresis
4.2.9 Centrifugation
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Pharmaceutical
4.3.2 Food & Cosmetics
4.3.3 Agriculture
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Microarray
5.2.2 Lab-on-a-chip
5.2.3 Biochip
5.2.4 Magnetic separation
5.2.5 Chromatography
5.2.6 Flow cytometry
5.2.7 Membrane filtration
5.2.8 Electrophoresis
5.2.9 Centrifugation
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Pharmaceutical
5.3.2 Food & Cosmetics
5.3.3 Agriculture
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Microarray
6.2.2 Lab-on-a-chip
6.2.3 Biochip
6.2.4 Magnetic separation
6.2.5 Chromatography
6.2.6 Flow cytometry
6.2.7 Membrane filtration
6.2.8 Electrophoresis
6.2.9 Centrifugation
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Pharmaceutical
6.3.2 Food & Cosmetics
6.3.3 Agriculture
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Microarray
7.2.2 Lab-on-a-chip
7.2.3 Biochip
7.2.4 Magnetic separation
7.2.5 Chromatography
7.2.6 Flow cytometry
7.2.7 Membrane filtration
7.2.8 Electrophoresis
7.2.9 Centrifugation
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Pharmaceutical
7.3.2 Food & Cosmetics
7.3.3 Agriculture
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Microarray
8.2.2 Lab-on-a-chip
8.2.3 Biochip
8.2.4 Magnetic separation
8.2.5 Chromatography
8.2.6 Flow cytometry
8.2.7 Membrane filtration
8.2.8 Electrophoresis
8.2.9 Centrifugation
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Pharmaceutical
8.3.2 Food & Cosmetics
8.3.3 Agriculture
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Microarray
9.2.2 Lab-on-a-chip
9.2.3 Biochip
9.2.4 Magnetic separation
9.2.5 Chromatography
9.2.6 Flow cytometry
9.2.7 Membrane filtration
9.2.8 Electrophoresis
9.2.9 Centrifugation
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Pharmaceutical
9.3.2 Food & Cosmetics
9.3.3 Agriculture
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Thermo Fisher Scientific
10.1.2 GE Healthcare
10.1.3 Agilent Technologies;Shimadzu Corporation
10.1.4 bioM rieux SA
10.1.5 Bio-Rad Laboratories, Inc.
10.1.6 Hitachi Koki Co., Ltd.
10.1.7 Merck & Co., Inc.
10.1.8 QIAGEN
10.1.9 WATERS
10.1.10 Sartorius
10.1.11 PerkinElmer, Inc.
10.1.12 Danaher
10.1.13 Miltenyi Biotec
10.1.14 BD
10.2 Separation Systems for Commercial Biotechnology Sales Date of Major Players (2017-2020e)
10.2.1 Thermo Fisher Scientific
10.2.2 GE Healthcare
10.2.3 Agilent Technologies;Shimadzu Corporation
10.2.4 bioM rieux SA
10.2.5 Bio-Rad Laboratories, Inc.
10.2.6 Hitachi Koki Co., Ltd.
10.2.7 Merck & Co., Inc.
10.2.8 QIAGEN
10.2.9 WATERS
10.2.10 Sartorius
10.2.11 PerkinElmer, Inc.
10.2.12 Danaher
10.2.13 Miltenyi Biotec
10.2.14 BD
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Separation Systems for Commercial Biotechnology Product Type Overview
2.Table Separation Systems for Commercial Biotechnology Product Type Market Share List
3.Table Separation Systems for Commercial Biotechnology Product Type of Major Players
4.Table Brief Introduction of Thermo Fisher Scientific
5.Table Brief Introduction of GE Healthcare
6.Table Brief Introduction of Agilent Technologies;Shimadzu Corporation
7.Table Brief Introduction of bioM rieux SA
8.Table Brief Introduction of Bio-Rad Laboratories, Inc.
9.Table Brief Introduction of Hitachi Koki Co., Ltd.
10.Table Brief Introduction of Merck & Co., Inc.
11.Table Brief Introduction of QIAGEN
12.Table Brief Introduction of WATERS
13.Table Brief Introduction of Sartorius
14.Table Brief Introduction of PerkinElmer, Inc.
15.Table Brief Introduction of Danaher
16.Table Brief Introduction of Miltenyi Biotec
17.Table Brief Introduction of BD
18.Table Products & Services of Thermo Fisher Scientific
19.Table Products & Services of GE Healthcare
20.Table Products & Services of Agilent Technologies;Shimadzu Corporation
21.Table Products & Services of bioM rieux SA
22.Table Products & Services of Bio-Rad Laboratories, Inc.
23.Table Products & Services of Hitachi Koki Co., Ltd.
24.Table Products & Services of Merck & Co., Inc.
25.Table Products & Services of QIAGEN
26.Table Products & Services of WATERS
27.Table Products & Services of Sartorius
28.Table Products & Services of PerkinElmer, Inc.
29.Table Products & Services of Danaher
30.Table Products & Services of Miltenyi Biotec
31.Table Products & Services of BD
32.Table Market Distribution of Major Players
33.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
34.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
35.Table Global Separation Systems for Commercial Biotechnology Market Forecast (Million USD) by Region 2021f-2026f
36.Table Global Separation Systems for Commercial Biotechnology Market Forecast (Million USD) Share by Region 2021f-2026f
37.Table Global Separation Systems for Commercial Biotechnology Market Forecast (Million USD) by Demand 2021f-2026f
38.Table Global Separation Systems for Commercial Biotechnology Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
